An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients
2 other identifiers
observational
411
1 country
1
Brief Summary
The purpose of this study is to identify the issues that have greatest impact on QOL for patients with Charcot Marie Tooth (CMT) Disease. Patients who have -registered in the Inherited Neuropathies Consortium Contact Registry will be invited to participate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 20, 2015
CompletedFirst Posted
Study publicly available on registry
April 29, 2015
CompletedJune 14, 2017
June 1, 2017
11 months
April 20, 2015
June 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of participants affected by specific symptoms of CMT.
The percentage of subjects within the sample who have reported experience with the symptom will be calculated.
1 year
Secondary Outcomes (1)
Severity of impact of each identified symptom of CMT
1 year
Study Arms (1)
INC Contact Registry Participants
Adult CMT patients who have self-registered at the Inherited Neuropathies Consortium (INC) Contact Registry, a web-based contact registry developed and supported by the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Consortium (RDCRN), located at the University of South Florida.
Eligibility Criteria
Patients with CMT, 18 years or older, who have joined the Inherited Neuropathies Consortium RDCRN Contact Registry.
You may qualify if:
- Patients with CMT that are 18 years or older and have joined the INC RDCRN Contact Registry.
You may not qualify if:
- Does not have CMT.
- Does not read or speak English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RDCRN Data Management and Coordinating Center , Epidemiology Center; University of South Florida
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
David Herrmann, MBBCh
University of Rochester
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2015
First Posted
April 29, 2015
Study Start
July 1, 2012
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
June 14, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share